Erysipelas pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 13: Line 13:
[[Category:Disease]]
[[Category:Disease]]
[[Category:Infectious disease]]
[[Category:Infectious disease]]
{{WH}}
{{WS}}

Revision as of 20:54, 5 December 2012

Erysipelas Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Erysipelas from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Erysipelas pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Erysipelas pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Erysipelas pathophysiology

CDC on Erysipelas pathophysiology

Erysipelas pathophysiology in the news

Blogs on Erysipelas pathophysiology

Directions to Hospitals Treating Erysipelas

Risk calculators and risk factors for Erysipelas pathophysiology

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Historically, the face was most affected; today the legs are affected most often. [1] Erysipelas infections can enter the skin through minor trauma, eczema, surgical incisions and ulcers, and often originate from strep bacteria in the subject's own nasal passages.

References

  1. See eMedicine link

Template:WH Template:WS